rs7608692

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001228.5(CASP8):​c.-27+12124G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.207 in 152,114 control chromosomes in the GnomAD database, including 3,449 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3449 hom., cov: 32)

Consequence

CASP8
NM_001228.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.331

Publications

13 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001228.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
NM_001228.5
c.-27+12124G>A
intron
N/ANP_001219.2
CASP8
NM_001400648.1
c.-27+12124G>A
intron
N/ANP_001387577.1
CASP8
NM_001400651.1
c.-27+12124G>A
intron
N/ANP_001387580.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
ENST00000264275.9
TSL:1
c.-27+12124G>A
intron
N/AENSP00000264275.5
CASP8
ENST00000392258.7
TSL:1
c.-27+12124G>A
intron
N/AENSP00000376087.3
CASP8
ENST00000471383.5
TSL:1
n.250+12124G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.207
AC:
31443
AN:
151996
Hom.:
3452
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.202
Gnomad AMR
AF:
0.169
Gnomad ASJ
AF:
0.278
Gnomad EAS
AF:
0.293
Gnomad SAS
AF:
0.316
Gnomad FIN
AF:
0.292
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.219
Gnomad OTH
AF:
0.200
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.207
AC:
31434
AN:
152114
Hom.:
3449
Cov.:
32
AF XY:
0.210
AC XY:
15646
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.149
AC:
6187
AN:
41488
American (AMR)
AF:
0.168
AC:
2574
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
963
AN:
3470
East Asian (EAS)
AF:
0.293
AC:
1517
AN:
5172
South Asian (SAS)
AF:
0.316
AC:
1522
AN:
4816
European-Finnish (FIN)
AF:
0.292
AC:
3089
AN:
10580
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.219
AC:
14908
AN:
67982
Other (OTH)
AF:
0.196
AC:
414
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1281
2561
3842
5122
6403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
346
692
1038
1384
1730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.217
Hom.:
1442
Bravo
AF:
0.193
Asia WGS
AF:
0.298
AC:
1038
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
7.2
DANN
Benign
0.69
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7608692; hg19: chr2-202110959; API